Assyro AI

FDA Orange Book · active-ingredient family

Ethambutol hydrochloride

Ethambutol hydrochloride is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MYAMBUTOL · NDA 016320

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
MYAMBUTOLRLD×4KANCHAN HLTHCARENDA 016320ABApproved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
ETHAMBUTOL HYDROCHLORIDE×2LUPINANDA 078939ABJun 17, 2009
ETHAMBUTOL HYDROCHLORIDEBARRANDA 076057Nov 26, 2001
ETHAMBUTOL HYDROCHLORIDE×2EPIC PHARMA LLCANDA 075095ABNov 30, 1999

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ethambutol hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.